WHO Expert Committee on Specifications for Pharmaceutical Preparations : thirty-seventh report.
Saved in:
Superior document: | WHO technical report series, 908 |
---|---|
: | |
TeilnehmendeR: | |
Year of Publication: | 2003 |
Language: | English |
Series: | Technical report series (World Health Organization) ;
908. |
Online Access: | |
Physical Description: | viii, 145 p. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
500284793 |
---|---|
ctrlnum |
(MiAaPQ)500284793 (Au-PeEL)EBL284793 (CaPaEBR)ebr10040297 (OCoLC)191039475 |
collection |
bib_alma |
record_format |
marc |
spelling |
WHO Expert Committee on Specifications for Pharmaceutical Preparations. Meeting (37th : 2001 : Geneva, Switzerland) WHO Expert Committee on Specifications for Pharmaceutical Preparations [electronic resource] : thirty-seventh report. Geneva : World Health Organization, 2003. viii, 145 p. WHO technical report series, 0512-3054 ; 908 1. Introduction -- 2. General policy -- 3. Quality control--specifications and tests -- 4. Quality control--international reference materials -- 5. Quality control--national laboratories -- 6. Quality assurance--good manufacturing practices (GMP) -- 7. Quality assurance--inspection -- 8. Quality assurance--distribution and trade-related -- 9. Quality assurance--risk analysis -- 10. Quality assurance--drug supply -- 11. Quality assurance--storage -- 12. International Nonproprietary Names (INNs) Programme -- 13. Miscellaneous -- Annex 1. Recommendations on risk of transmitting animal spongiform encephalopathy agents via medicinal products -- Annex 2. The International Pharmacopoeia: revised concepts and future perspectives -- Annex 3. Guidelines on good manufacturing practices for radiopharmaceutical products -- Annex 4. Good manufacturing practices for pharmaceutial products: main prinicples -- Annex 5. Model certificate of good manufacturing practices -- Annex 6. Guidance on good manufacturing practices (GMP): inspection report -- Annex 7. Application of hazard analysis and critical control point (HACCP) method to pharmaceuticals -- Annex 8. Procedure for assessing the acceptability, in principle, of pharmaceutical products for purchase by United Nations agencies -- Annex 9. Guide to good storage practices for pharmaceuticals. Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries. Drugs Standards Congresses. Drugs Specifications Congresses. Pharmaceutical industry Quality control Congresses. Electronic books. ProQuest (Firm) Technical report series (World Health Organization) ; 908. https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=284793 Click to View |
language |
English |
format |
Electronic eBook |
author2 |
ProQuest (Firm) |
author_facet |
ProQuest (Firm) WHO Expert Committee on Specifications for Pharmaceutical Preparations. Meeting ProQuest (Firm) |
author2_role |
TeilnehmendeR |
author_corporate |
WHO Expert Committee on Specifications for Pharmaceutical Preparations. Meeting ProQuest (Firm) |
author_sort |
WHO Expert Committee on Specifications for Pharmaceutical Preparations. Meeting |
title |
WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report. |
spellingShingle |
WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report. WHO technical report series, 1. Introduction -- 2. General policy -- 3. Quality control--specifications and tests -- 4. Quality control--international reference materials -- 5. Quality control--national laboratories -- 6. Quality assurance--good manufacturing practices (GMP) -- 7. Quality assurance--inspection -- 8. Quality assurance--distribution and trade-related -- 9. Quality assurance--risk analysis -- 10. Quality assurance--drug supply -- 11. Quality assurance--storage -- 12. International Nonproprietary Names (INNs) Programme -- 13. Miscellaneous -- Annex 1. Recommendations on risk of transmitting animal spongiform encephalopathy agents via medicinal products -- Annex 2. The International Pharmacopoeia: revised concepts and future perspectives -- Annex 3. Guidelines on good manufacturing practices for radiopharmaceutical products -- Annex 4. Good manufacturing practices for pharmaceutial products: main prinicples -- Annex 5. Model certificate of good manufacturing practices -- Annex 6. Guidance on good manufacturing practices (GMP): inspection report -- Annex 7. Application of hazard analysis and critical control point (HACCP) method to pharmaceuticals -- Annex 8. Procedure for assessing the acceptability, in principle, of pharmaceutical products for purchase by United Nations agencies -- Annex 9. Guide to good storage practices for pharmaceuticals. |
title_sub |
thirty-seventh report. |
title_full |
WHO Expert Committee on Specifications for Pharmaceutical Preparations [electronic resource] : thirty-seventh report. |
title_fullStr |
WHO Expert Committee on Specifications for Pharmaceutical Preparations [electronic resource] : thirty-seventh report. |
title_full_unstemmed |
WHO Expert Committee on Specifications for Pharmaceutical Preparations [electronic resource] : thirty-seventh report. |
title_auth |
WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report. |
title_new |
WHO Expert Committee on Specifications for Pharmaceutical Preparations |
title_sort |
who expert committee on specifications for pharmaceutical preparations thirty-seventh report. |
series |
WHO technical report series, |
series2 |
WHO technical report series, |
publisher |
World Health Organization, |
publishDate |
2003 |
physical |
viii, 145 p. |
contents |
1. Introduction -- 2. General policy -- 3. Quality control--specifications and tests -- 4. Quality control--international reference materials -- 5. Quality control--national laboratories -- 6. Quality assurance--good manufacturing practices (GMP) -- 7. Quality assurance--inspection -- 8. Quality assurance--distribution and trade-related -- 9. Quality assurance--risk analysis -- 10. Quality assurance--drug supply -- 11. Quality assurance--storage -- 12. International Nonproprietary Names (INNs) Programme -- 13. Miscellaneous -- Annex 1. Recommendations on risk of transmitting animal spongiform encephalopathy agents via medicinal products -- Annex 2. The International Pharmacopoeia: revised concepts and future perspectives -- Annex 3. Guidelines on good manufacturing practices for radiopharmaceutical products -- Annex 4. Good manufacturing practices for pharmaceutial products: main prinicples -- Annex 5. Model certificate of good manufacturing practices -- Annex 6. Guidance on good manufacturing practices (GMP): inspection report -- Annex 7. Application of hazard analysis and critical control point (HACCP) method to pharmaceuticals -- Annex 8. Procedure for assessing the acceptability, in principle, of pharmaceutical products for purchase by United Nations agencies -- Annex 9. Guide to good storage practices for pharmaceuticals. |
issn |
0512-3054 ; |
callnumber-first |
R - Medicine |
callnumber-subject |
RA - Public Medicine |
callnumber-label |
RA8 |
callnumber-sort |
RA 18 A247 W46 42003 |
genre |
Electronic books. |
genre_facet |
Congresses. Electronic books. |
url |
https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=284793 |
illustrated |
Not Illustrated |
oclc_num |
191039475 |
work_keys_str_mv |
AT whoexpertcommitteeonspecificationsforpharmaceuticalpreparationsmeeting whoexpertcommitteeonspecificationsforpharmaceuticalpreparationsthirtyseventhreport AT proquestfirm whoexpertcommitteeonspecificationsforpharmaceuticalpreparationsthirtyseventhreport |
status_str |
n |
ids_txt_mv |
(MiAaPQ)500284793 (Au-PeEL)EBL284793 (CaPaEBR)ebr10040297 (OCoLC)191039475 |
hierarchy_parent_title |
WHO technical report series, 908 |
hierarchy_sequence |
908. |
is_hierarchy_title |
WHO Expert Committee on Specifications for Pharmaceutical Preparations thirty-seventh report. |
container_title |
WHO technical report series, 908 |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1792330675927384064 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02807nam a2200349Ia 4500</leader><controlfield tag="001">500284793</controlfield><controlfield tag="003">MiAaPQ</controlfield><controlfield tag="005">20200520144314.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">030508s2003 sz s o000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9241209089</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)500284793</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL284793</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CaPaEBR)ebr10040297</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)191039475</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RA8.A247</subfield><subfield code="b">W46 2003</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">WHO Expert Committee on Specifications for Pharmaceutical Preparations.</subfield><subfield code="b">Meeting</subfield><subfield code="n">(37th :</subfield><subfield code="d">2001 :</subfield><subfield code="c">Geneva, Switzerland)</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">WHO Expert Committee on Specifications for Pharmaceutical Preparations</subfield><subfield code="h">[electronic resource] :</subfield><subfield code="b">thirty-seventh report.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Geneva :</subfield><subfield code="b">World Health Organization,</subfield><subfield code="c">2003.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">viii, 145 p.</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">WHO technical report series,</subfield><subfield code="x">0512-3054 ;</subfield><subfield code="v">908</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">1. Introduction -- 2. General policy -- 3. Quality control--specifications and tests -- 4. Quality control--international reference materials -- 5. Quality control--national laboratories -- 6. Quality assurance--good manufacturing practices (GMP) -- 7. Quality assurance--inspection -- 8. Quality assurance--distribution and trade-related -- 9. Quality assurance--risk analysis -- 10. Quality assurance--drug supply -- 11. Quality assurance--storage -- 12. International Nonproprietary Names (INNs) Programme -- 13. Miscellaneous -- Annex 1. Recommendations on risk of transmitting animal spongiform encephalopathy agents via medicinal products -- Annex 2. The International Pharmacopoeia: revised concepts and future perspectives -- Annex 3. Guidelines on good manufacturing practices for radiopharmaceutical products -- Annex 4. Good manufacturing practices for pharmaceutial products: main prinicples -- Annex 5. Model certificate of good manufacturing practices -- Annex 6. Guidance on good manufacturing practices (GMP): inspection report -- Annex 7. Application of hazard analysis and critical control point (HACCP) method to pharmaceuticals -- Annex 8. Procedure for assessing the acceptability, in principle, of pharmaceutical products for purchase by United Nations agencies -- Annex 9. Guide to good storage practices for pharmaceuticals.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="a">Electronic reproduction. Ann Arbor, MI : ProQuest, 2015. Available via World Wide Web. Access may be limited to ProQuest affiliated libraries.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Standards</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Specifications</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Quality control</subfield><subfield code="v">Congresses.</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic books.</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">ProQuest (Firm)</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Technical report series (World Health Organization) ;</subfield><subfield code="v">908.</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=284793</subfield><subfield code="z">Click to View</subfield></datafield></record></collection> |